It is a healthcare private limited company based in Alappuzha, Kerala, India, established in 2019.
2019 | Alappuzha, Kerala, India | ActiveKanthariplus Suraksha Pharma Private Limited, a active private limited company, was established on 03 December 2019 in Alappuzha, Kerala, India. Engaging in preventive health services within the hospital and medical care sector, it holds CIN: U24290KL2019PTC060592. Registered under ROC Roc Ernakulam. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
Its leadership includes Vijayakumari (Director), Krishnamallan Gopinathamallan (Director), Balakrishnan Murali (Director). Past directors included . Vijayakumari, Krishnamallan Gopinathamallan, Balakrishnan Murali. It holds ₹4.90 M open charges and no settled loans. Its latest AGM occurred on 31 August 2024, with the balance sheet filed on 31 March 2024. It is based at Vii/70, Sree Krishna Bhavan Mayithara P.O Cherthala Alappuzha Kl 688539 In, Alappuzha, Kerala, 688539.
U24290KL2019PTC060592
060592
03 December 2019
₹1.00 M
₹1.00 M
Roc Ernakulam
Unlisted
Active
Explore comprehensive insights into Kanthariplus Suraksha Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vijayakumari | Director | 10 Jul 2023 | Current |
| Krishnamallan Gopinathamallan | Director | 10 Jul 2023 | Current |
| Balakrishnan Murali | Director | 10 Jul 2023 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2023 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2023 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2023 | Past |
| Pramod Abcsdd | Additional Director | 12 Jul 2023 | Past |
| Pramod Abcsdd | Managing Director | 03 Sep 2021 | Past |
| Pramod Abcsdd | Director | 12 Jul 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Kanthariplus Suraksha Pharma Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 1064.61% increase in profit. The company's net worth moved up by a moderate rise of 4.9%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Kanthariplus Suraksha Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹4,900,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Mar 2024 | Others | ₹4.90 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Kanthariplus Suraksha Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Kanthariplus Suraksha Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kanthariplus Suraksha Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Kanthariplus Suraksha Pharma Private Limited last Annual general meeting of members was held on 31 Aug 2024 as per latest MCA records. was completed.
Kanthariplus Suraksha Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ernakulam. was recorded as a recent event.
The activity A charge with Others amounted to Rs. 4.90 M with Charge ID 100919004 was registered on 26 Mar 2024. was completed.
The activity Vijayakumari was appointed as a Director was appointed as a Director on 10 Jul 2023 & has been associated with this company since 2 years 4 months . was completed.
Krishnamallan Gopinathamallan was appointed as a Director was appointed as a Director on 10 Jul 2023 & has been associated with this company since 2 years 4 months . was recorded as a recent event.
Progress on Balakrishnan Murali was appointed as a Director was appointed as a Director on 10 Jul 2023 & has been associated with this company since 2 years 4 months . was documented.
The CIN of Kanthariplus Suraksha Pharma Private Limited is U24290KL2019PTC060592.
Kanthariplus Suraksha Pharma Private Limited is headquartered at Vii/70, Sree Krishna Bhavan Mayithara P.O Cherthala Alappuzha Kl 688539 In, Alappuzha, Kerala, 688539.
Kanthariplus Suraksha Pharma Private Limited was incorporated on 03 December 2019.
The current directors of Kanthariplus Suraksha Pharma Private Limited are
The primary industry of Kanthariplus Suraksha Pharma Private Limited is Hospital And Medical Care.
Kanthariplus Suraksha Pharma Private Limited is unlisted.
The authorized capital of Kanthariplus Suraksha Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX